Anne Braun

Title: The Innovative Contributions of Anne Braun

Introduction

Anne Braun is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of medical research, particularly in the treatment of atherosclerosis and heart disease. Her innovative work has led to the development of a unique animal model that aids in screening compounds for therapeutic benefits.

Latest Patents

Anne Braun holds a patent for her groundbreaking work titled "Screening of compounds for treatment of atherosclerosis and heart attack." This patent describes transgenic animals that do not express functional SR-BI and ApoE, which develop severe atherosclerosis by the age of four weeks. These animals also exhibit progressive heart dysfunction and typically die by nine weeks. The model has proven useful for screening compounds that alleviate symptoms of atherosclerosis and heart disease. Notably, animals fed with PROBUCOL from mating showed a normal phenotype at six weeks, demonstrating the compound's preventative action. In contrast, those not fed PROBUCOL had a significantly higher mortality rate.

Career Highlights

Anne Braun is affiliated with the Massachusetts Institute of Technology, where she continues her research and innovation in the medical field. Her work has garnered attention for its potential to improve treatment options for heart disease and related conditions.

Collaborations

Anne has collaborated with notable researchers, including Monty Krieger and Helena E. Miettinen, to advance her research and findings in the field.

Conclusion

Anne Braun's contributions to medical research through her innovative patent and collaborative efforts highlight her role as a leading inventor in the fight against heart disease. Her work continues to pave the way for new therapeutic approaches and improved patient outcomes.